1. "MSK Grad Students"
Formats
  1. Journal Article (1632)
  2. Meeting Abstract (966)
  3. Review (105)
  4. Editorial (42)
  5. Research Letter (35)
  6. Miscellaneous (19)
  7. Correspondence (15)
  8. Conference Paper (12)
  9. Book Section (9)
  10. Guidelines (6)
Groups
  1. MSK Grad Students (2841)
  2. GSK Faculty (1992)
  3. Department of Medicine (1593)
  4. Sloan Kettering Institute Postdocs (1580)
  5. Sloan Kettering Institute Faculty (1300)
  6. Center for Hematologic Malignancies (1110)

More Groups

People
  1. Sergio Giralt (393)
  2. Miguel-Angel Perales (377)
  3. Parastoo Dahi (294)
  4. Sean Devlin (277)
  5. Doris Ponce (254)
  6. Roni Tamari (209)

More People

Years
  1. 2025 (95)
  2. 2024 (256)
  3. 2023 (312)
  4. 2022 (334)
  5. 2021 (289)
  6. 2020 (378)

More Years

Publications
  1. Blood (294)
  2. Biology of Blood and Marrow Transplantation (165)
  3. Cancer Research (132)
  4. Journal of Clinical Oncology (127)
  5. Nature Communications (96)
  6. Nature (85)

More Publications

Publishers
  1. Nature Publishing Group (435)
  2. American Society of Hematology (331)
  3. Elsevier Inc. (298)
  4. Cell Press (272)
  5. American Association for Cancer Research (265)
  6. American Society of Clinical Oncology (143)

More Publishers

Results (2841)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Delta-like ligand 3 (DLL3) is a novel target for molecular imaging of neuroendocrine prostate cancer
    Meeting Abstract

    Korsen, J.; Kalidindi, T.; Khitrov, S.; Khuram, H.; Piorier, J.; Rudin, C.; Chen, Y.; Pillarsetty, N. V. K.; Lewis, J.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients on the LIBRETTO-001 trial
    Meeting Abstract

    Subbiah, V.; Gainor, J. F.; Oxnard, G. R.; Tan, D. S. W.; Owen, D. H.; Cho, B. C.; Loong, H. H. F.; McCoach, C. E.; Weiss, J.; Kim, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/II study of GB1275, a first-in-class oral CD11b modulator, alone, and combined with pembrolizumab in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (KEYNOTE-A36)
    Meeting Abstract

    Rasco, D. W.; Bendell, J. C.; Wang-Gillam, A.; Park, W.; O'Reilly, E. M.; Zhou, L.; Galkin, A.; Carter, L. L.; Nickle, D.; Li, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Ongoing, first-in-human, phase I dose escalation study of the investigational CD47-blocker TTI-622 in patients with advanced relapsed or refractory lymphoma
    Meeting Abstract

    Patel, K.; Maris, M. B.; Cheson, B. D.; Zonder, J. A.; Lesokhin, A. M.; Von Keudell, G.; Seymour, E. K.; Lin, G. H. Y.; Catalano, T.; Shou, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in hepatopancreaticobiliary (HPB) cancers
    Meeting Abstract

    Park, W.; Sokol, E.; Chen, J.; Yu, K. H.; Khalil, D.; Harding, J. J.; El Dika, I. H.; Riaz, N.; Abou-Alfa, G. K.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small cell lung cancer
    Meeting Abstract

    Goto, K.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T. M.; Gainor, J. F.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Activating mutations in uveal melanoma convey sensitivity to g-alpha q inhibition
    Meeting Abstract

    Hitchman, T. D.; Ceraudo, E.; Moore, A. R.; Shoushtari, A. N.; Francis, J. H.; Guan, Y.; Chen, J.; Chang, M. T.; Taylor, B. S.; Sakmar, T. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save